IL63136A - Stabilized 7beta-(alpha-carboxy-alpha-(p-hydroxyphenyl acetamido) 7alpha-methoxy-3-heterocyclylthiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylic acid alkali metal salt preparations and process for preparing them - Google Patents

Stabilized 7beta-(alpha-carboxy-alpha-(p-hydroxyphenyl acetamido) 7alpha-methoxy-3-heterocyclylthiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylic acid alkali metal salt preparations and process for preparing them

Info

Publication number
IL63136A
IL63136A IL63136A IL6313681A IL63136A IL 63136 A IL63136 A IL 63136A IL 63136 A IL63136 A IL 63136A IL 6313681 A IL6313681 A IL 6313681A IL 63136 A IL63136 A IL 63136A
Authority
IL
Israel
Prior art keywords
alpha
heterocyclylthiomethyl
dethia
7beta
7alpha
Prior art date
Application number
IL63136A
Other languages
English (en)
Other versions
IL63136A0 (en
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of IL63136A0 publication Critical patent/IL63136A0/xx
Publication of IL63136A publication Critical patent/IL63136A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL63136A 1980-06-23 1981-06-21 Stabilized 7beta-(alpha-carboxy-alpha-(p-hydroxyphenyl acetamido) 7alpha-methoxy-3-heterocyclylthiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylic acid alkali metal salt preparations and process for preparing them IL63136A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8578980A JPS5711909A (en) 1980-06-23 1980-06-23 Stable freeze-dried preparation of beta-lactam

Publications (2)

Publication Number Publication Date
IL63136A0 IL63136A0 (en) 1981-09-13
IL63136A true IL63136A (en) 1984-07-31

Family

ID=13868648

Family Applications (1)

Application Number Title Priority Date Filing Date
IL63136A IL63136A (en) 1980-06-23 1981-06-21 Stabilized 7beta-(alpha-carboxy-alpha-(p-hydroxyphenyl acetamido) 7alpha-methoxy-3-heterocyclylthiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylic acid alkali metal salt preparations and process for preparing them

Country Status (31)

Country Link
US (1) US4418058A (nl)
JP (1) JPS5711909A (nl)
KR (1) KR840000693B1 (nl)
AR (1) AR230007A1 (nl)
AT (1) AT380790B (nl)
AU (1) AU541627B2 (nl)
BE (1) BE889351A (nl)
BG (1) BG37991A3 (nl)
CA (1) CA1164801A (nl)
CH (1) CH648210A5 (nl)
CS (1) CS221835B2 (nl)
DD (1) DD159879A5 (nl)
DE (1) DE3124592A1 (nl)
DK (1) DK158443C (nl)
ES (1) ES503283A0 (nl)
FI (1) FI75490C (nl)
FR (1) FR2484835A1 (nl)
GB (1) GB2078737B (nl)
GR (1) GR75646B (nl)
HU (1) HU183494B (nl)
IE (1) IE51331B1 (nl)
IL (1) IL63136A (nl)
IT (1) IT1144812B (nl)
NL (1) NL191777C (nl)
NO (1) NO156036C (nl)
NZ (1) NZ197414A (nl)
PT (1) PT73239B (nl)
RO (1) RO82720B (nl)
SE (1) SE460702B (nl)
YU (1) YU44416B (nl)
ZA (1) ZA814203B (nl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597193A (ja) * 1982-07-02 1984-01-14 Shionogi & Co Ltd マロニルメチル基の異性化方法
JPS6045514A (ja) * 1983-08-22 1985-03-12 Shionogi & Co Ltd 安定な抗菌性凍結乾燥製剤
US4797388A (en) * 1984-05-21 1989-01-10 Cetus Corporation Pharmaceutical compositions with galactitol as carrier
US4891391A (en) * 1985-01-03 1990-01-02 Morton Thiokol, Inc. Compositions containing antimicrobial agents in combination with stabilizers
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones
DE3801179A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierung von cephalosporinderivaten durch trocknung mit einem stabilisator sowie stabile zubereitungsformen mit cephalosporinderivaten
CN1556712A (zh) * 2000-07-13 2004-12-22 ��һ��������ҩ��ʽ���� 含dds化合物的药用组合物
US7378408B2 (en) * 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
EP2777705A1 (en) 2013-03-15 2014-09-17 Cubist Pharmaceuticals, Inc. Ceftolozane antibiotic compositions
US20140274993A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane-tazobactam pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS532931B2 (nl) * 1973-12-05 1978-02-01
US3928592A (en) * 1974-02-22 1975-12-23 Lilly Co Eli Antibiotic pharmaceutical compositions
US3993753A (en) * 1974-08-26 1976-11-23 American Home Products Corporation Anhydrous ampicillin stabilization and resultant compositions
GB1463563A (en) * 1974-10-10 1977-02-02 Beecham Group Ltd Pharmaceutical compositions
JPS5151511A (en) * 1974-10-25 1976-05-07 Tooru Tatsuhara Aminosanseizai no anteikaho
US4180571A (en) * 1976-03-25 1979-12-25 Shionogi & Co., Ltd. Arylmalonamido-1-oxadethiacephalosporins
JPS532931A (en) * 1976-06-30 1978-01-12 Saraya Kk Toilet bowl cleaning method
BE861876A (fr) * 1976-12-17 1978-06-15 Scherico Ltd Nouvelles formulations d'antibiotiques beta-lactame leur procede de preparation, melange antibiotique injectable ainsi que son procede de preparation
JPS53104722A (en) * 1977-02-19 1978-09-12 Tsumura Juntendo Kk Production of powder for making herb medicine liquid agent
CA1127450A (en) * 1978-08-26 1982-07-13 Gordon L. Mcglennon Load multiplying mechanisms
US4259485A (en) * 1979-04-24 1981-03-31 Eli Lilly And Company Crystallization process

Also Published As

Publication number Publication date
IT8167863A0 (it) 1981-06-22
SE460702B (sv) 1989-11-13
PT73239B (en) 1982-07-22
ES8203887A1 (es) 1982-04-01
ES503283A0 (es) 1982-04-01
AR230007A1 (es) 1984-02-29
ZA814203B (en) 1982-09-29
NO156036B (no) 1987-04-06
GB2078737A (en) 1982-01-13
YU157381A (en) 1984-10-31
BG37991A3 (en) 1985-09-16
FI811948L (fi) 1981-12-24
CH648210A5 (de) 1985-03-15
NO156036C (no) 1987-07-15
FI75490C (fi) 1988-07-11
JPS5711909A (en) 1982-01-21
RO82720A (ro) 1984-05-23
FR2484835A1 (fr) 1981-12-24
US4418058A (en) 1983-11-29
FI75490B (fi) 1988-03-31
CA1164801A (en) 1984-04-03
NL191777B (nl) 1996-04-01
DE3124592A1 (de) 1982-02-11
AT380790B (de) 1986-07-10
SE8103904L (sv) 1981-12-24
KR840000693B1 (ko) 1984-05-21
YU44416B (en) 1990-08-31
DE3124592C2 (nl) 1990-12-20
PT73239A (en) 1981-07-01
DK158443C (da) 1990-10-08
NL191777C (nl) 1996-08-02
GR75646B (nl) 1984-08-02
IE51331B1 (en) 1986-12-10
BE889351A (fr) 1981-10-16
KR830005848A (ko) 1983-09-14
IT1144812B (it) 1986-10-29
NZ197414A (en) 1984-10-19
AU7209781A (en) 1983-01-06
DK274981A (da) 1981-12-24
NL8102943A (nl) 1982-01-18
DK158443B (da) 1990-05-21
AU541627B2 (en) 1985-01-17
ATA278881A (de) 1985-12-15
CS221835B2 (en) 1983-04-29
IE811347L (en) 1981-12-23
HU183494B (en) 1984-05-28
DD159879A5 (de) 1983-04-13
FR2484835B1 (nl) 1983-07-01
JPS6364405B2 (nl) 1988-12-12
IL63136A0 (en) 1981-09-13
RO82720B (ro) 1984-07-30
GB2078737B (en) 1984-03-14
NO812090L (no) 1981-12-28

Similar Documents

Publication Publication Date Title
YU43985B (en) Process for micro-encapsulation of bikampicillin acid salts
HUT35641A (en) Process for preparing 1-benzyl-amino-alkyl-pirrolidinones and acid addition salts thereof
IL63136A (en) Stabilized 7beta-(alpha-carboxy-alpha-(p-hydroxyphenyl acetamido) 7alpha-methoxy-3-heterocyclylthiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylic acid alkali metal salt preparations and process for preparing them
PL238024A1 (en) Process for preparing stable salts of s-adenosilmethionine
DE3165107D1 (en) Process for the stabilisation of aqueous solutions of acetoacetamides
IL72731A (en) Stable antibacterial lyophilizate preparations of 7-difluoromethyl thioacetamino-7-methoxy-3-(1-(2-hydroxy lower alkyl)-1h-tetrazol-5-yl)thio-methyl-1-dethia-1-oxa-3-cephem-4-carboxylic acid alkali metal salts and methods for the production thereof
PT75054B (en) Process for preparing acid halide and acyllactam functional materials
DE3271938D1 (en) Process for the preparation of urea
EG15796A (en) Process for preparing of hexahydro-trans-and tetrahydropyridoindole neurolptic agents
DE3263557D1 (en) Process for the preparation of quinolinic acid
MTP906B (en) Ammonium salt of a substituted carboxylic acid process for their manufacture their use and their pharmaceutical preparations containing them
DE3260364D1 (en) Process for preparing vinyl-phosphonic acid
DE3167735D1 (en) Process for the preparation of alkali metal salts of imidodisulphonic acid
DE3260188D1 (en) Process for preparing vinyl-phosphonic acid
DE3265553D1 (en) Novel secalonic acid derivatives and method for preparing thereof
YU233783A (en) Process for obtaining alpha-hydroxy-beta-haloethyl-phosphinic acid and salts thereof
DE3367772D1 (en) Process for the preparation of 3-carboxy-1-methylpyrrol-2-acetic-acid and alkali metal salts thereof
PT74257B (en) Process for preparing aqueous micellar solutions of levonantra-dol and n-methyllevonantradol
IL72798A0 (en) Process for the preparation of an aqueous solution of sodium chloride
DE3463264D1 (en) Process for the preparation of 4-nitrotoluene-2-sulfonic acid
EP0077537A3 (en) Process for preparing 6-chloro-3-toluidino-4-sulphonic acid
ZA825789B (en) Process for the preparation of urea
DE3568029D1 (en) Process for the preparation of ammonium salt containing manganese (ii) salt solutions
GB2101133B (en) Process for preparing the acid chloride of carnitine
DE3260872D1 (en) Novel thienyloxazolylacetic acid derivatives and process for preparing same

Legal Events

Date Code Title Description
KB Patent renewed
EXP Patent expired